Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial.
By B. Culleton, M. Walsh, S. Klarenbach, G. Mortis, Narine Scott-Douglas, R. Quinn, Marcello Tonelli, S. Donnelly, M. Friedrich, Andreas Kumar and 3 more. Journal of the American Medical Association (JAMA), 2007
689 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Nephrology, Public Health, Environmental and Occupational Health
View Paper: https://www.semanticscholar.org/paper/76cf23b79df2bfcd1b752b547b757dce94d60db4
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Nephrology
Citations in the corpus
- KDOQI Clinical Practice Guideline for Hemodialysis Adequacy: 2015 update. (2015, methodology): “) Unfortunately, results from these trials were equivocal due to very small sample sizes (Alberta Trial, N 5 52; FHN Nocturnal Trial, N 5 87).(8,11) Both trials demonstrated statistically better BP and phosphate control with home long frequent HD, but no improvement in anemia.”
- Hemodialysis-induced cardiac injury: determinants and associated outcomes. (2009, background): “More frequent daily or nocturnal HD therapies can improve cardiovascular outcome measures and quality of life (26,27).”